(Q35799761)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15188938%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

review article

1 reference

title

Lipoprotein(a): new insights into mechanisms of atherogenesis and thrombosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15188938%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15188938%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Arjun Deb

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15188938%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

1 May 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15188938%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15188938%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15188938%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15188938%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

258-264

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15188938%20AND%20SRC:MED&resulttype=core&format=json

A prospective study of lipoprotein(a) and the risk of myocardial infarction

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960270503

Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960270503

Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960270503

Lipoprotein(a): intrigues and insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960270503

Lipoprotein(a) in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960270503

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960270503

Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960270503

cDNA sequence of human apolipoprotein(a) is homologous to plasminogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960270503

The apolipoprotein(a) gene resides on human chromosome 6q26?27, in close proximity to the homologous gene for plasminogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960270503

Linkage between the loci for the Lp(a) lipoprotein (LP) and plasminogen (PLG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960270503

The apolipoprotein(a) kringle IV repeats which differ from the major repeat kringle are present in variably-sized isoforms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960270503

Molecular definition of the extreme size polymorphism in apolipoprotein(a).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960270503

Structural basis for the presumptive atherothrombogenic action of lipoprotein(a). Facts and speculations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960270503

Polymorphonuclear cells isolated from human peripheral blood cleave lipoprotein(a) and apolipoprotein(a) at multiple interkringle sites via the enzyme elastase. Generation of mini-Lp(a) particles and apo(a) fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960270503

Macrophage metalloelastase, MMP-12, cleaves human apolipoprotein(a) in the linker region between kringles IV-4 and IV-5. Potential relevance to lipoprotein(a) biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960270503

MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960270503

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960270503

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960270503

Genetic manipulation of vascular adhesion molecules in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960270503

Activation of transforming growth factor-beta is inhibited in transgenic apolipoprotein(a) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960270503

Transforming growth factor beta decreases the rate of proliferation of rat vascular smooth muscle cells by extending the G2 phase of the cell cycle and delays the rise in cyclic AMP before entry into M phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960270503

Subendothelial retention of lipoprotein (a). Evidence that reduced heparan sulfate promotes lipoprotein binding to subendothelial matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960270503

Lipoprotein(a) vascular accumulation in mice. In vivo analysis of the role of lysine binding sites using recombinant adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960270503

Modification of apolipoprotein(a) lysine binding site reduces atherosclerosis in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960270503

Expression of decorin by sprouting bovine aortic endothelial cells exhibiting angiogenesis in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960270503

Stimulation of interleukin-8 production in human THP-1 macrophages by apolipoprotein(a). Evidence for a critical involvement of elements in its C-terminal domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960270503

Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960270503

Interleukin-8 is chemotactic for vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960270503

Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960270503

Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960270503

Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960270503

Inhibition of inducible nitric oxide synthesis by oxidized lipoprotein(a) in a murine macrophage cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960270503

Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960270503

Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960270503

Further characterization of the cellular plasminogen binding site: evidence that plasminogen 2 and lipoprotein a compete for the same site

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960270503

A potential basis for the thrombotic risks associated with lipoprotein(a).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960270503

Cell surface annexin II is a high affinity receptor for the alternatively spliced segment of tenascin-C

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960270503

Endothelial cell-mediated conversion of Glu-plasminogen to Lys-plasminogen. Further evidence for assembly of the fibrinolytic system on the endothelial cell surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960270503

Binding of tissue plasminogen activator to cultured human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960270503

Antifibrinolytic activity of apolipoprotein(a) in vivo: Human apolipoprotein(a) transgenic mice are resistant to tissue plasminogen activator-mediated thrombolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960270503

Plasmin catalyzes binding of lipoprotein (a) to immobilized fibrinogen and fibrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960270503

Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960270503

Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960270503

MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960270503

Increased expression of u-PA and u-PAR on monocytes by LDL and Lp(a) lipoproteins--consequences for plasmin generation and monocyte adhesion

21 January 2018

1 reference

12 December 2020

A role of plasminogen in atherosclerosis and restenosis models in mice

1 reference

12 December 2020

Lipoprotein (a) up-regulates the expression of the plasminogen activator inhibitor 2 in human blood monocytes

1 reference

12 December 2020

Inhibition of fibrinolysis by lipoprotein(a).

1 reference

12 December 2020

Molecular characterization of vascular smooth muscle decorin: deduced core protein structure and regulation of gene expression

1 reference

12 December 2020

Malondialdehyde modification of lipoprotein(a) produces avid uptake by human monocyte-macrophages

1 reference

12 December 2020

Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men

1 reference

12 December 2020

Activation of factor X and its regulation by tissue factor pathway inhibitor in small-diameter capillaries lined with human endothelial cells

1 reference

12 December 2020

Lp(a) lipoprotein/pre-ß1-lipoprotein in Swedish middle-aged males and in patients with coronary heart disease

1 reference

12 December 2020

Differential expression of small chondroitin/dermatan sulfate proteoglycans, PG-I/biglycan and PG-II/decorin, by vascular smooth muscle and endothelial cells in culture

1 reference

12 December 2020

Lipoprotein (a) regulates plasminogen activator inhibitor-1 expression in endothelial cells. A potential mechanism in thrombogenesis

1 reference

12 December 2020

Tissue-type plasminogen activator binds to and is inhibited by surface-bound lipoprotein(a) and low-density lipoprotein

1 reference

12 December 2020

Oscillations of intracellular calcium induced by vasopressin in individual fura-2-loaded mesangial cells. Frequency dependence on basal calcium concentration, agonist concentration, and temperature

1 reference

12 December 2020

Identification and characterization of human endothelial cell membrane binding sites for tissue plasminogen activator and urokinase

1 reference

12 December 2020

Lipoprotein (a) and plasminogen are immunochemically related

1 reference

12 December 2020

Lipoprotein a inhibits streptokinase-mediated activation of human plasminogen

1 reference

12 December 2020

Inhibition of rat mesangial cell mitogenesis by nitric oxide-generating vasodilators

1 reference

12 December 2020

The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes

1 reference

12 December 2020

Physicochemical properties of apolipoprotein(a) and lipoprotein(a-) derived from the dissociation of human plasma lipoprotein (a)

1 reference

12 December 2020

The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action

1 reference

12 December 2020

Binding of plasminogen to cultured human endothelial cells

1 reference

12 December 2020

Radioimmunoassay of human plasma Lp(a) lipoprotein

1 reference

12 December 2020

Studies on an extra pre-beta lipoprotein fraction

1 reference

12 December 2020

Inhibition of platelet function by organic nitrate vasodilators

1 reference

12 December 2020

Studies of hypercholesterolemia in the nonhuman primate. II. Fatty streak conversion to fibrous plaque.

1 reference

12 December 2020

Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits

1 reference

12 December 2020

Multiple binding with identical linkage: a mechanism that explains the effect of lipoprotein(a) on fibrinolysis

1 reference

12 December 2020

Influence of plasma lipoprotein (a) levels on coronary vasomotor response to acetylcholine

1 reference

12 December 2020

Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells

1 reference

12 December 2020

Apolipoproteins and ischaemic heart disease: implications for screening

1 reference

12 December 2020

A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study

1 reference

12 December 2020

Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS).

1 reference

12 December 2020

Interleukin-8. A mitogen and chemoattractant for vascular smooth muscle cells

1 reference

12 December 2020

Expression of tissue factor and tissue factor pathway inhibitor in monocytes in response to bacterial lipopolysaccharide and phorbolester

1 reference

12 December 2020

An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II.

1 reference

12 December 2020

An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation

1 reference

12 December 2020

Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial

1 reference

12 December 2020

Long-term inhibition of NO synthesis promotes atherosclerosis in the hypercholesterolemic rabbit thoracic aorta. PGH2 does not contribute to impaired endothelium-dependent relaxation

1 reference

12 December 2020

Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries

1 reference

12 December 2020

Does apolipoprotein(a) heterogeneity influence lipoprotein(a) effects on fibrinolysis?

1 reference

12 December 2020

Lipoprotein lipase and sphingomyelinase synergistically enhance the association of atherogenic lipoproteins with smooth muscle cells and extracellular matrix. A possible mechanism for low density lipoprotein and lipoprotein(a) retention and macropha

1 reference

12 December 2020

Cholesterol loading of macrophages leads to marked enhancement of native lipoprotein(a) and apoprotein(a) internalization and degradation

1 reference

12 December 2020

Lipoprotein(a) binds to human platelets and attenuates plasminogen binding and activation

1 reference

12 December 2020

Distribution of tissue factor pathway inhibitor in normal and malignant human tissues

1 reference

12 December 2020

Proliferation of human smooth muscle cells promoted by lipoprotein(a)

1 reference

12 December 2020

Role of nitric oxide and phosphodiesterase isoenzyme II for reduction of endothelial hyperpermeability.

1 reference

12 December 2020

Levels of soluble cell adhesion molecules in patients with dyslipidemia

1 reference

12 December 2020

Interleukin-8 production by macrophages from atheromatous plaques

1 reference

12 December 2020

Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study

1 reference

12 December 2020

Identification of active tissue factor in human coronary atheroma

1 reference

12 December 2020

Functional and metabolic differences between elastase-generated fragments of human lipoprotein[a] and apolipoprotein[a]

1 reference

12 December 2020

Lipoprotein Lp(a) excess and coronary heart disease

1 reference

12 December 2020

Learning about the structure and biology of human lipoprotein [a] through dissection by enzymes of the elastase family: facts and speculations

1 reference

12 December 2020

Does Lipoprotein(a) Impair Endothelial Function?

1 reference

12 December 2020

Lipoprotein(a) enhances the expression of intercellular adhesion molecule-1 in cultured human umbilical vein endothelial cells

1 reference

12 December 2020

Epidemiology of Lp(a) lipoprotein: its role in atherosclerotic/thrombotic disease.

1 reference

12 December 2020

Lipoprotein(a): identification of subjects with a superbinding capacity for fibrinogen.

1 reference

12 December 2020

Apolipoprotein(a) binds via its C-terminal domain to the protein core of the proteoglycan decorin. Implications for the retention of lipoprotein(a) in atherosclerotic lesions

1 reference

12 December 2020

Presence of tissue factor pathway inhibitor in human atherosclerotic plaques is associated with reduced tissue factor activity.

1 reference

12 December 2020

Atherothrombogenicity of lipoprotein(a): the debate

1 reference

12 December 2020

Expression of adhesion molecules by lp(a): a potential novel mechanism for its atherogenicity

1 reference

12 December 2020

Interleukin-8 mediates downregulation of tissue inhibitor of metalloproteinase-1 expression in cholesterol-loaded human macrophages: relevance to stability of atherosclerotic plaque

1 reference

12 December 2020

Identifiers

DOI

10.1002/CLC.4960270503

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15188938%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15188938%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15188938%20AND%20SRC:MED&resulttype=core&format=json